Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Tri Chemical Laboratories Inc. (4369.T)
JPY3,610.00
+210.00 (+6.18%)
JP JPX Basic Materials Chemicals - Specialty
Address
8154-217, Uenohara 409-0112
Uenohara, JP
Uenohara, JP
CEO
Kiyoshi Tazuke
Website
trichemical.com
IPO
2007-08-03
ISIN JP3636000006
Description
Founded in 1978 and headquartered in Uenohara, Japan, Tri Chemical Laboratories Inc. develops and supplies essential chemical compounds for cutting-edge industries. The company provides crucial precursors for the production of semiconductors, optical fibers, solar cells, and compound semiconductors. Additionally, its chemical offerings include catalysts and various specialized reagents. Beyond chemicals, Tri Chemical Laboratories Inc. also manufactures a comprehensive selection of containment products, such as stainless-steel vessels equipped with valves, seamless cylinders for high-pressure gas applications, glass ampoules, and a range of bottles made from polyethylene or glass.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
JPY3,610.00
+210.00 (+6.18%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
680.7K
Beta
1.58
Float Shares
27.64M
Free Float %
85.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +11.01% | +13.41% | +30.78% | +10.28% | +49.89% | +49.09% | +50.76% | +69.23% | +21.83% | +742.48% | +2,162.16% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
3,610.00
DCF (Unlevered)
423.50
-88.3%
DCF (Levered)
1,927.70
-46.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
75% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 2 | -1 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
9.35
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
4 / 10
Developing
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
4 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Chemicals - Specialty: +4.7%+26.3% ★ Q2'26: +14.0% (vs Q2'25)
-
EPS growth Chemicals - Specialty: +13.2%+11.2% Q2'26: +53.6% (vs Q2'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+9.8% ★ Q2'26: -8.6% (vs Q2'25)
-
EBIT margin Chemicals - Specialty: +8.8%+24.7% ★ Q2'26: +27.6% (vs Q2'25)
-
ROIC Chemicals - Specialty: +5.6%+13.9% ★ Q2'26: +17.6% (vs Q2'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q2'26: 0.0% (vs Q2'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.53× ★ Q2'26: 0.58× (vs Q2'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Jan 2016 actual |
Jan 2017 actual |
Jan 2018 actual |
Jan 2019 actual |
Jan 2020 actual |
Jan 2021 actual |
Jan 2022 actual |
Jan 2023 actual |
Jan 2024 actual |
Jan 2025 actual |
Jan 2026 5 Rev. Ana. 5 EPS Ana. |
Jan 2027 5 Rev. Ana. 5 EPS Ana. |
Jan 2028 5 Rev. Ana. 5 EPS Ana. |
Jan 2029 4 Rev. Ana. 4 EPS Ana. |
Jan 2030 3 Rev. Ana. 2 EPS Ana. |
Jan 2031 2 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
4.96B
est: 4.95B (+0.1%)
|
5.47B
est: 5.65B (-3.2%)
|
6.45B
est: 6.40B (+0.7%)
|
7.79B
est: 7.90B (-1.4%)
|
8.27B
est: 8.34B (-0.8%)
|
9.80B
est: 9.85B (-0.5%)
|
11.57B
est: 11.61B (-0.3%)
|
13.80B
est: 13.53B (+2.0%)
|
11.25B
est: 13.60B (-17.3%)
|
18.91B
est: 18.58B (+1.7%)
|
23.94B
23.26B – 24.44B
+28.8% YoY
|
28.62B
27.40B – 30.09B
+19.5% YoY
|
31.86B
30.00B – 34.71B
+11.3% YoY
|
35.21B
33.42B – 37.73B
+10.5% YoY
|
38.00B
36.06B – 40.71B
+7.9% YoY
|
41.00B
38.91B – 43.93B
+7.9% YoY
|
| EBITDA |
988.25M
est: 2.35B (-58.0%)
|
1.31B
est: 2.68B (-51.0%)
|
1.97B
est: 3.04B (-35.1%)
|
2.64B
est: 3.75B (-29.7%)
|
2.97B
est: 3.96B (-25.0%)
|
3.51B
est: 4.68B (-25.0%)
|
4.00B
est: 5.51B (-27.5%)
|
4.71B
est: 6.43B (-26.6%)
|
3.25B
est: 4.50B (-27.7%)
|
6.63B
est: 6.15B (+7.8%)
|
7.92B
7.70B – 8.09B
+28.8% YoY
|
9.47B
9.06B – 9.95B
+19.5% YoY
|
10.54B
9.92B – 11.48B
+11.3% YoY
|
11.65B
11.05B – 12.48B
+10.5% YoY
|
12.57B
11.93B – 13.47B
+7.9% YoY
|
13.56B
12.87B – 14.53B
+7.9% YoY
|
| EBIT |
721.77M
est: 1.91B (-62.2%)
|
976.99M
est: 2.18B (-55.1%)
|
1.60B
est: 2.47B (-35.2%)
|
2.15B
est: 3.04B (-29.3%)
|
2.33B
est: 3.21B (-27.6%)
|
2.69B
est: 3.80B (-29.1%)
|
2.98B
est: 4.47B (-33.4%)
|
3.50B
est: 5.21B (-32.8%)
|
1.95B
est: 3.29B (-40.8%)
|
5.26B
est: 4.50B (+16.9%)
|
5.79B
5.63B – 5.91B
+28.8% YoY
|
6.92B
6.63B – 7.28B
+19.5% YoY
|
7.71B
7.26B – 8.40B
+11.3% YoY
|
8.52B
8.08B – 9.12B
+10.5% YoY
|
9.19B
8.72B – 9.85B
+7.9% YoY
|
9.92B
9.41B – 10.63B
+7.9% YoY
|
| Net Income |
473.22M
est: 481.77M (-1.8%)
|
767.31M
est: 781.55M (-1.8%)
|
1.15B
est: 1.25B (-8.2%)
|
2.27B
est: 2.39B (-5.2%)
|
2.94B
est: 2.80B (+4.9%)
|
3.38B
est: 3.57B (-5.3%)
|
4.10B
est: 4.36B (-6.2%)
|
4.83B
est: 5.50B (-12.1%)
|
2.47B
est: 3.05B (-18.9%)
|
4.96B
est: 4.91B (+1.1%)
|
5.41B
4.99B – 5.84B
+10.2% YoY
|
5.52B
4.76B – 6.65B
+2.0% YoY
|
6.01B
5.02B – 7.54B
+8.8% YoY
|
7.26B
6.56B – 8.38B
+20.8% YoY
|
7.90B
7.38B – 8.63B
+8.9% YoY
|
8.80B
8.22B – 9.62B
+11.4% YoY
|
| SGA |
901.12M
est: 602.00M (+49.7%)
|
825.39M
est: 687.13M (+20.1%)
|
979.08M
est: 778.34M (+25.8%)
|
1.02B
est: 960.76M (+6.2%)
|
1.10B
est: 1.01B (+9.0%)
|
1.18B
est: 1.20B (-1.8%)
|
1.31B
est: 1.41B (-7.5%)
|
1.44B
est: 1.65B (-12.6%)
|
1.41B
est: 1.58B (-10.7%)
|
2.03B
est: 2.16B (-5.8%)
|
2.78B
2.70B – 2.84B
+28.8% YoY
|
3.32B
3.18B – 3.49B
+19.5% YoY
|
3.70B
3.48B – 4.03B
+11.3% YoY
|
4.09B
3.88B – 4.38B
+10.5% YoY
|
4.41B
4.18B – 4.72B
+7.9% YoY
|
4.76B
4.51B – 5.10B
+7.9% YoY
|
| EPS |
15.44
est: 14.83 (+4.1%)
|
24.58
est: 24.05 (+2.2%)
|
36.66
est: 38.40 (-4.5%)
|
72.56
est: 73.60 (-1.4%)
|
94.08
est: 86.24 (+9.1%)
|
108.08
est: 109.76 (-1.5%)
|
126.33
est: 134.30 (-5.9%)
|
148.70
est: 168.66 (-11.8%)
|
76.03
est: 93.79 (-18.9%)
|
152.69
est: 149.09 (+2.4%)
|
164.37
153.49 – 179.63
+10.2% YoY
|
169.95
146.48 – 204.76
+3.4% YoY
|
184.98
154.48 – 231.89
+8.8% YoY
|
223.43
201.87 – 257.96
+20.8% YoY
|
243.10
227.01 – 265.67
+8.8% YoY
|
270.80
252.87 – 295.95
+11.4% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-28 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-27 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-26 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-25 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-22 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-21 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-20 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-19 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-18 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-15 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-14 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-13 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-12 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-01 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-30 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-1.23B
OE per share TTM
-37.80
Owner's Yield
-1.00%
Maintenance CapEx ratio
96.24%
Maint CapEx / Avg PPE
69.4%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 80 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P International Small Cap ETF GWX | 0.07% | 597.6K | 0.40% |
| 2 | Dimensional - International Small Cap ETF DFIS | 0.06% | 3.30M | 0.39% |
| 3 | WisdomTree Japan SmallCap Dividend Fund DFJ | 0.04% | 170.3K | 0.58% |
| 4 | iShares MSCI Japan Small Cap UCITS ETF IDJP.L | 0.04% | 246.6K | 0.58% |
| 5 | iShares MSCI Japan Small-Cap ETF SCJ | 0.04% | 99.1K | 0.50% |
| 6 | Schwab International Small-Cap Equity ETF SCHC | 0.02% | 1.28M | 0.06% |
| 7 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.02% | 2.46M | 0.06% |
| 8 | WisdomTree International Equity Fund DWM | 0.02% | 102.8K | 0.48% |
| 9 | iShares Currency Hedged MSCI EAFE Small-Cap ETF HSCZ | 0.02% | 34.8K | 0.83% |
| 10 | iShares MSCI EAFE Small-Cap ETF SCZ | 0.02% | 2.10M | 0.40% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
21.54M
Shares Outstanding
32.50M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Akira Tabaru | Executive Officer of Quality Manager Department | — | — |
| Hironobu Ohsugi | Executive Officer & Director | — | male |
| Kiyoshi Tazuke | President, Chief Executive Officer, Manager & Representative Director | — | male |
| Masahito Shibata | Executive Officer | — | male |
| Satoru Mihashi | Executive Officer of Technology Development Department | — | — |
| Tadaaki Hiraki | Executive Officer of Safety Promotion Department | — | — |
| Takashi Udagawa | Executive Officer of Sales of Japan & South Korea | — | male |
| Tatsuya Ohira | Executive Officer of Sales of Taiwan of China | — | male |
| Yoshihide Suzuki | Executive Officer & Director | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4369.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
